Personalized medicine in nonalcoholic fatty liver disease

Autores
Pirola, Carlos Jose; Sookoian, Silvia Cristina
Año de publicación
2022
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
The keystone of precision medicine in complex traits is to predict the onset and progression of the disease. While there are different paths toward precision medicine,1 genetic assessment may be among the top strategies. The current knowledge of the complete human genome sequence and the availability of next-generation sequencing technologies2 to decipher individual patients’ genetic make-up also invite fully integrated genomic medicine. Therefore, patients may be classified into high or low risk for disease onset or severity, and therapeutic interventions can be personalized. Most importantly, precision medicine must ensure health benefits across geography, ethnicity, age, and gender...
Fil: Pirola, Carlos Jose. Universidad Abierta Interamericana. Secretaría de Investigación. Centro de Altos Estudios En Ciencias Humanas y de la Salud - Sede Buenos Aires.; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Médicas. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Médicas; Argentina
Fil: Sookoian, Silvia Cristina. Universidad Abierta Interamericana. Secretaría de Investigación. Centro de Altos Estudios En Ciencias Humanas y de la Salud - Sede Buenos Aires.; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Médicas. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Médicas; Argentina
Materia
NAFLD
NASH
GENETICS
PERSONALIZED MEDICINE
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/224150
Acceder
id CONICETDig_b29b5333558eb7c682607ad580fdd90a
oai_identifier_str oai:ri.conicet.gov.ar:11336/224150
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Personalized medicine in nonalcoholic fatty liver diseasePirola, Carlos JoseSookoian, Silvia CristinaNAFLDNASHGENETICSPERSONALIZED MEDICINEhttps://purl.org/becyt/ford/3.2https://purl.org/becyt/ford/3The keystone of precision medicine in complex traits is to predict the onset and progression of the disease. While there are different paths toward precision medicine,1 genetic assessment may be among the top strategies. The current knowledge of the complete human genome sequence and the availability of next-generation sequencing technologies2 to decipher individual patients’ genetic make-up also invite fully integrated genomic medicine. Therefore, patients may be classified into high or low risk for disease onset or severity, and therapeutic interventions can be personalized. Most importantly, precision medicine must ensure health benefits across geography, ethnicity, age, and gender...Fil: Pirola, Carlos Jose. Universidad Abierta Interamericana. Secretaría de Investigación. Centro de Altos Estudios En Ciencias Humanas y de la Salud - Sede Buenos Aires.; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Médicas. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Médicas; ArgentinaFil: Sookoian, Silvia Cristina. Universidad Abierta Interamericana. Secretaría de Investigación. Centro de Altos Estudios En Ciencias Humanas y de la Salud - Sede Buenos Aires.; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Médicas. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Médicas; ArgentinaKorean Association for the Study of the Liver2022-06info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/224150Pirola, Carlos Jose; Sookoian, Silvia Cristina; Personalized medicine in nonalcoholic fatty liver disease; Korean Association for the Study of the Liver; Clinical and Molecular Hepatology; 28; 4; 6-2022; 935-9382287-27282287-285XCONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://www.e-cmh.org/journal/view.php?doi=10.3350/cmh.2022.0175info:eu-repo/semantics/altIdentifier/doi/10.3350/cmh.2022.0175info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T10:09:53Zoai:ri.conicet.gov.ar:11336/224150instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 10:09:54.238CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Personalized medicine in nonalcoholic fatty liver disease
title Personalized medicine in nonalcoholic fatty liver disease
spellingShingle Personalized medicine in nonalcoholic fatty liver disease
Pirola, Carlos Jose
NAFLD
NASH
GENETICS
PERSONALIZED MEDICINE
title_short Personalized medicine in nonalcoholic fatty liver disease
title_full Personalized medicine in nonalcoholic fatty liver disease
title_fullStr Personalized medicine in nonalcoholic fatty liver disease
title_full_unstemmed Personalized medicine in nonalcoholic fatty liver disease
title_sort Personalized medicine in nonalcoholic fatty liver disease
dc.creator.none.fl_str_mv Pirola, Carlos Jose
Sookoian, Silvia Cristina
author Pirola, Carlos Jose
author_facet Pirola, Carlos Jose
Sookoian, Silvia Cristina
author_role author
author2 Sookoian, Silvia Cristina
author2_role author
dc.subject.none.fl_str_mv NAFLD
NASH
GENETICS
PERSONALIZED MEDICINE
topic NAFLD
NASH
GENETICS
PERSONALIZED MEDICINE
purl_subject.fl_str_mv https://purl.org/becyt/ford/3.2
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv The keystone of precision medicine in complex traits is to predict the onset and progression of the disease. While there are different paths toward precision medicine,1 genetic assessment may be among the top strategies. The current knowledge of the complete human genome sequence and the availability of next-generation sequencing technologies2 to decipher individual patients’ genetic make-up also invite fully integrated genomic medicine. Therefore, patients may be classified into high or low risk for disease onset or severity, and therapeutic interventions can be personalized. Most importantly, precision medicine must ensure health benefits across geography, ethnicity, age, and gender...
Fil: Pirola, Carlos Jose. Universidad Abierta Interamericana. Secretaría de Investigación. Centro de Altos Estudios En Ciencias Humanas y de la Salud - Sede Buenos Aires.; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Médicas. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Médicas; Argentina
Fil: Sookoian, Silvia Cristina. Universidad Abierta Interamericana. Secretaría de Investigación. Centro de Altos Estudios En Ciencias Humanas y de la Salud - Sede Buenos Aires.; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Médicas. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Médicas; Argentina
description The keystone of precision medicine in complex traits is to predict the onset and progression of the disease. While there are different paths toward precision medicine,1 genetic assessment may be among the top strategies. The current knowledge of the complete human genome sequence and the availability of next-generation sequencing technologies2 to decipher individual patients’ genetic make-up also invite fully integrated genomic medicine. Therefore, patients may be classified into high or low risk for disease onset or severity, and therapeutic interventions can be personalized. Most importantly, precision medicine must ensure health benefits across geography, ethnicity, age, and gender...
publishDate 2022
dc.date.none.fl_str_mv 2022-06
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/224150
Pirola, Carlos Jose; Sookoian, Silvia Cristina; Personalized medicine in nonalcoholic fatty liver disease; Korean Association for the Study of the Liver; Clinical and Molecular Hepatology; 28; 4; 6-2022; 935-938
2287-2728
2287-285X
CONICET Digital
CONICET
url http://hdl.handle.net/11336/224150
identifier_str_mv Pirola, Carlos Jose; Sookoian, Silvia Cristina; Personalized medicine in nonalcoholic fatty liver disease; Korean Association for the Study of the Liver; Clinical and Molecular Hepatology; 28; 4; 6-2022; 935-938
2287-2728
2287-285X
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/url/https://www.e-cmh.org/journal/view.php?doi=10.3350/cmh.2022.0175
info:eu-repo/semantics/altIdentifier/doi/10.3350/cmh.2022.0175
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
application/pdf
dc.publisher.none.fl_str_mv Korean Association for the Study of the Liver
publisher.none.fl_str_mv Korean Association for the Study of the Liver
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1842270098524471296
score 13.13397

Publicaciones similares